Familial Hypercholesterolemia Diagnosis and Management
- Familial hypercholesterolemia (FH) is one of the most common and single severe gene disorders, affecting approximately 30 million people worldwide.
- One baby with FH is born globally every minute.
- While statins and ezetimibe constitute first-line therapy, they provide less than optimal LDL-C reduction in severe FH.
- In particular, homozygous FH requires combination therapy, high-dose statin and ezetimibe, with or without apheresis.
Dr. prof frederick raal
Professor Raal is currently Professor and Head of the Division of Endocrinology and Metabolism, as well as Director of the Carbohydrate and Lipid Metabolism Research Unit, University of the Witwatersrand, Johannesburg, South Africa. Prof frederick raal is a Frederick J. Raal, MBBCh, FRCP, FCP(SA), Cert Endo, MMED, PhD Head, Division of Endocrinology & Metabolism Director, Carbohydrate and Lipid Metabolism Research Unit Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
More FAQs by Dr. prof frederick raal
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article